Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 4
Submit an article Journal homepage
156
Views
10
CrossRef citations to date
0
Altmetric
Brief Report

Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation

Jeremy P. Hing Johnson & Johnson Pharmaceutical Research & Development, Raritan, NJ, USA
,
Vladimir Piotrovsky Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium
,
Hui Kimko Johnson & Johnson Pharmaceutical Research & Development, Raritan, NJ, USA
,
H. Robert Brashear Johnson & Johnson Pharmaceutical Research & Development, Titusville, NJ, USA
&
Qinying Zhao Johnson & Johnson Pharmaceutical Research & Development, Titusville, NJ, USACorrespondence[email protected]
Pages 483-487 | Accepted 17 Feb 2005, Published online: 04 Apr 2005

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Antonio Di Stefano, Antonio Iannitelli, Sara Laserra & Piera Sozio. (2011) Drug delivery strategies for Alzheimer's disease treatment. Expert Opinion on Drug Delivery 8:5, pages 581-603.
Read now
Ben Seltzer. (2010) Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease. Clinical Interventions in Aging 5, pages 1-6.
Read now
Bindu P. Murthy, Donna M. Skee, Alexander P. Danyluk, Vincent Brett, Gary J. Vorsanger & Bruce L. Moskovitz. (2007) Pharmacokinetic model and simulations of dose conversion from immediate- to extended-release tramadol. Current Medical Research and Opinion 23:2, pages 275-284.
Read now

Articles from other publishers (7)

Dong Wook Kang, Seok-jin Cho, Go-Wun Choi & Hea-Young Cho. (2022) Strategies for developing Alzheimer’s disease treatments: application of population pharmacokinetic and pharmacodynamic models. Journal of Pharmaceutical Investigation 52:5, pages 519-538.
Crossref
I. V. Kolykhalov. (2016) Current approaches to optimize treatment of dementia and Alzheimer's disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:6, pages 87.
Crossref
Jeffrey L. Cummings, Richard S. Isaacson, Frederick A. Schmitt & Drew M. Velting. (2015) A practical algorithm for managing Alzheimer's disease: what, when, and why?. Annals of Clinical and Translational Neurology 2:3, pages 307-323.
Crossref
Katrien Van Puyvelde & Tony Mets. (2011) Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: A study in a real life population. Geriatrics & Gerontology International 11:3, pages 256-261.
Crossref
Jiong Shi & Ben Seltzer. (2011) Galantamine: an update. Neurodegenerative Disease Management 1:3, pages 227-234.
Crossref
Katharina Kuester, Andreas Kovar, Christian Lüpfert, Brigitte Brockhaus & Charlotte Kloft. (2009) Refinement of the Population Pharmacokinetic Model for the Monoclonal Antibody Matuzumab. Clinical Pharmacokinetics 48:7, pages 477-487.
Crossref
Nazem Bassil & George T. Grossberg. (2009) Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimerʼs Disease. CNS Drugs 23:4, pages 293-307.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.